0393-6155

The International Journal of Biological Markers

SAGE Publications

View prefix report (10.1177)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 1793 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1793 DOIs
2

Add abstracts to 645 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact645 DOIs
3

Deposit reference lists for 463 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact463 DOIs

DOIs for this ISSN

Showing the top 5 of 2015 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Bravais-Pearson and Spearman Correlation Coefficients: Meani… (10.1177/172460080201700213)
Abstract ORCID
110.74 163
2 Pooled Analysis of uPA and PAI-1 for Prognosis in Primary Br… (10.1177/172460080001500113)
Abstract References ORCID
78.10 10
3 Validity of the Dmba-Induced Mammary Cancer Model for the St… (10.1177/172460088700200312)
Abstract ORCID
73.12 28
4 Clinical and Experimental Studies of Cysteine Cathepsins and… (10.1177/172460080001500117)
Abstract ORCID
68.09 22
5 Circulating Tumor Markers: A Guide to their Appropriate Clin… (10.5301/jbm.5000251)
Abstract ORCID
65.05 19
6 A Guide for Reviewing Submitted Manuscripts: (And Indication… (10.1177/172460089901400301)
Abstract ORCID
63.94 18
7 CA 125: The past and the Future (10.1177/172460089801300402)
ORCID
62.83 325
8 Circulating Tumor Markers: A Guide to Their Appropriate Clin… (10.5301/ijbm.5000259)
Abstract ORCID
60.21 15
9 Effects of Oncological Surgery on Endothelin-1 Secretion in… (10.1177/172460080001500110)
Abstract ORCID
58.80 14
10 Circulating Tumor Markers: A Guide to their Appropriate Clin… (10.5301/ijbm.5000272)
Abstract ORCID
58.80 14
11 NATO Advanced Study Institute on “Radiolabeled Monoclonal An… (10.1177/172460088700200106)
Abstract References ORCID
58.36 5
12 A Brief Guide to the Practice of Radioimmunoscintigraphy and… (10.1177/172460088900400208)
Abstract ORCID
57.31 13
13 Tissue polypeptide specific antigen (TPS) and objective resp… (10.1177/172460089200700111)
Abstract ORCID
57.31 13
14 SPan-1 and Exocrine Pancreatic Carcinoma. The Clinical Role… (10.1177/172460080101600306)
Abstract ORCID
55.70 12
15 Serum Ca 15.3 Levels in Patients with Non-Tumoral Diseases,… (10.1177/172460088600100308)
Abstract ORCID
55.70 12
16 EGFR as a clinical marker in glioblastomas and other gliomas (10.5301/ijbm.5000301)
ORCID
55.24 161
17 Cysteine Proteinases and Their Inhibitors in Extracellular F… (10.1177/172460080001500116)
ORCID
53.42 136
18 Biostatistics and Tumor Marker Studies in Breast Cancer: Des… (10.1177/172460080301800107)
Abstract ORCID
52.07 10
19 Overweight, Obesity and Endometrial Cancer Risk: Results fro… (10.5301/jbm.5000047)
ORCID
52.07 120
20 CA 15–3: A Prognostic Marker in Breast Cancer (10.1177/172460080001500410)
ORCID
50.94 108
21 The Potential Role of Akt Phosphorylation in Human Cancers (10.1177/172460080802300101)
ORCID
50.73 106
22 Mammary Cancer Model Induced by Dimethylbenz(a)Anthracene: A… (10.1177/172460088700200210)
Abstract ORCID
50.00 9
23 CA 15.3 Behaviour in Cystic Breast Disease (10.1177/172460088900400309)
Abstract ORCID
50.00 9
24 CA 125 in Benign Gynecological Conditions (10.1177/172460089801300411)
ORCID
49.21 92
25 Cytokeratins in the Histological Diagnosis of Malignant Tumo… (10.1177/172460089400900201)
ORCID
48.86 89
26 Clinical Evaluation of Lentil Lectin-Reactive Alpha-Fetoprot… (10.1177/172460080101600204)
ORCID
48.73 88
27 Prognostic Role of C-Reactive Protein in Breast Cancer: A Sy… (10.5301/jbm.2011.8872)
ORCID
48.73 88
28 Human MUC1 Mucin: A Multifaceted Glycoprotein (10.1177/172460080001500413)
ORCID
48.24 84
29 CEA Serum Levels in Non-Neoplastic Disease (10.1177/172460089200700307)
ORCID
48.11 83
30 Serum Albumin Levels in Relation to Tumor Parameters in Hepa… (10.5301/ijbm.5000300)
ORCID
48.11 83
31 Soluble Urokinase Plasminogen Activator Receptor Measurement… (10.1177/172460080101600402)
ORCID
47.85 81
32 Efficacy of Cancer Chemotherapy in Relation to the Pretreatm… (10.1177/172460080401900208)
ORCID
47.71 80
33 Evidence of a Relationship between High Serum Ca 125 and Liv… (10.1177/172460088600100109)
Abstract ORCID
47.71 8
34 Metallothionein: A Multifunctional Protein from Toxicity to… (10.1177/172460080301800302)
ORCID
46.88 74
35 Treatment of a Patient with b Cell Lymphoma by 1-131 Lym-1 M… (10.1177/172460088700200107)
ORCID
46.58 72
36 A Sensitive and Robust Assay for Urokinase and Tissue-Type P… (10.1177/172460089701200102)
ORCID
45.81 67
37 The Role of the Thiol N-Acetylcysteine in the Prevention of… (10.1177/172460089901400413)
ORCID
45.81 67
38 Neuron-Specific Enolase (10.1177/172460089400900401)
ORCID
45.32 64
39 Corrigendum to Serum exosomal miR-451a acts as a candidate m… (10.1177/03936155221086337)
Abstract References ORCID
45.15 3
40 Screening for Prostate Cancer by PSA Determination: A Time f… (10.1177/172460080001500401)
Abstract ORCID
45.15 7
41 Circulating Angiogenesis Regulators in Cancer Patients (10.1177/172460080101600102)
ORCID
45.15 63
42 Behavior of Prostatic Specific Antigen (Psa) in Spinal Fluid… (10.1177/172460088600100210)
Abstract ORCID
45.15 7
43 CYFRA 21.1 Cytosolic Levels in Breast Diseases. Correlation… (10.1177/172460089601100205)
Abstract ORCID
45.15 7
44 Health Care Expenditure, Laboratory Services and IVD Market (10.1177/172460089701200301)
Abstract References ORCID
45.15 3
45 More than 15 Years of CA 125: What is Known about the Antige… (10.1177/172460089801300403)
ORCID
45.15 63
46 Stem Cell Marker Aldehyde Dehydrogenase 1 (ALDH1)-Expressing… (10.5301/jbm.5000048)
ORCID
44.98 62
47 PD-L1 Gene Polymorphism and High Level of Plasma Soluble Pd-… (10.5301/jbm.5000170)
ORCID
44.63 60
48 In Vitro Models of Angiogenesis: The use of Matrigel (10.1177/172460089901400408)
ORCID
44.45 59
49 Prognostic value of pretreatment prognostic nutritional inde… (10.1177/1724600818799876)
ORCID
44.27 58
50 Disappearance Rate of Serum Calcitonin after Total Thyroidec… (10.1177/172460089400900104)
ORCID
44.27 58